• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Anika Therapeutics Inc

+ Add to Watchlist


42.5001 USD 7.2499 14.57%

As of 12:13:28 ET on 07/31/2014.

Snapshot for Anika Therapeutics Inc (ANIK)

Open: 46.4900 Day's Range: 42.2500 - 47.3500 Volume: 976,760
Previous Close: 49.7500 52wk Range: 19.9400 - 52.4900 1-Yr Rtn: +111.34%

Stock Chart for ANIK

No chart data available.
  • ANIK:US 42.5100
  • 1D
  • 1M
  • 1Y
Interactive ANIK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ANIK

Current P/E Ratio (ttm) 18.1764
Estimated P/E(12/2014) 18.3190
Relative P/E vs. SPX 1.0111
Earnings Per Share (USD) (ttm) 2.3382
Est. EPS (USD) (12/2014) 2.3200
Est. PEG Ratio 0.6106
Market Cap (M USD) 612.91
Shares Outstanding (M) 14.42
30 Day Average Volume 278,568
Price/Book (mrq) 3.8728
Price/Sale (ttm) 6.1352
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ANIK

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ANIK

Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products and devices. The Company's products, based on hyaluronic acid, promote the repair, protection, and healing of bone, cartilage, and soft tissue. Anika's products include ORTHOVISC and HYVISC which treat osteoarthritis.

Charles H SherwoodPresident/CEOSylvia CheungCFO/Treasurer/Secretary
Carol A BarnettChief Commercial OfficerJohn W Sheets JrChief Scientific Officer
More Company Profile & Key Executives for ANIK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil